['heart failure']
['neladenoson bialanate (bay1067197)', 'neladenoson bialanate (bay1067197)', 'neladenoson bialanate (bay1067197)', 'neladenoson bialanate (bay1067197)', 'neladenoson bialanate (bay1067197)', 'placebo']

        Inclusion Criteria:

          -  Men or women aged 18 years and older

          -  Diagnosis of chronic heart failure (CHF), NYHA ( New York Heart Association ) class
             II-IV, LVEF ≤ 35% and elevated NT-proBNP

        Exclusion Criteria:

          -  Acute de-novo heart failure

          -  Requirement of any intravenous (IV) treatments following 48 hours prior to
             randomization

          -  Mechanical support (e.g. intra-aortic balloon pump, endotracheal intubation,
             mechanical ventilation, or any ventricular assist device)

          -  Any cause of chronic heart failure other than ischemic cardiomyopathy and idiopathic
             dilated cardiomyopathy
      